SNIPR BIOME

Description

SNIPR BIOME develops CRISPR-based medicines that use bacteriophages, engineered probiotics, and CRISPR systems to target antibiotic-resistant bacteria with precision for antimicrobial-resistance and difficult-to-treat disease care.

SNIPR BIOME is located in the Copenhagen ecosystem.

Related

• NovonesisNovonesis brings sales and distribution together with research and innovation for animal feed enzymes, microbes, and probiotics, supporting…
• CamurusCamurus develops and commercializes long-acting pharmaceutical medicines using its proprietary FluidCrystal technology for treatment of…
• LEO PharmaLEO Pharma develops and delivers innovative treatments for medical dermatology, producing medicines and supplying healthcare providers and…
• Hansa BiopharmaHansa Biopharma develops immunomodulating antibody-cleaving enzyme therapies that target and inactivate IgG antibodies, inhibiting…
• Novo NordiskNovo Nordisk develops treatments and support for serious chronic diseases by applying scientific expertise and understanding of people’s…
• BiosyntiaBiosyntia produces natural ingredients using proprietary microbial fermentation processes, selecting and integrating engineered microbes…
• CysbioCysbio builds engineered bacterial cell factories and proprietary bioprocesses to produce amino acids, sulfated biochemicals and…
• QQFactoryQFactory designs and fabricates nanomechanical resonators with acoustic traps, engineered for ultra-low mechanical loss and high quality…
• Molecular PartnersMolecular Partners develops DARPin therapeutics, including Radio-DARPins and logic-gated Switch-DARPins, to target DLL3, FAP x CD40, and…